Physician profile
Brian N Bennett
NPI 1275639692
$4,084.27
in general payments reported to CMS, 2019-2025
37 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $1,437 · 2021: $671 · 2022: $678 · 2023: $412 · 2024: $440 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,269.63 | 2020-2025 | |
| Smith+Nephew, INC. | $426.24 | 2019-2025 | Collagenase Santyl, Vlp Foot, Grafix Pl |
| Horizon Therapeutics Plc | $272.85 | 2020-2022 | |
| Ibsa Pharma INC. | $251.03 | 2021-2024 | Tirosint, Licart, Tirosint |
| Depuy Synthes Sales INC. | $246.32 | 2021-2023 | Na, Motoband, N/A |
| Bioventus LLC | $197.06 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $189.64 | 2020-2023 | Puraply |
| Nevro Corp. | $141.75 | 2021-2024 | Senza |
| Crossroads Extremity Systems, LLC | $121.39 | 2020-2021 | |
| Melinta Therapeutics, LLC | $94.21 | 2021-2022 | |
| Boston Scientific Corporation | $87.42 | 2020-2024 | Varithena Administration Pack |
| Abbvie INC. | $79.88 | 2021-2023 | Dalvance |
| Extremity Medical | $70.34 | 2019 | |
| Paratek Pharmaceuticals, INC. | $68.60 | 2024-2025 | Nuzyra |
| Stryker Corporation | $68.01 | 2021-2025 | Alphavent |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $66.18 | 2021-2022 | |
| Solventum Corporation | $46.59 | 2025 | Snap, Activ.A.C., Promogran Prisma |
| In2bones USA, LLC | $33.16 | 2022 | |
| Glenmark Therapeutics INC. | $33.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $30.63 | 2022 | |
| Pfizer INC. | $29.99 | 2020 | |
| Zyla Life Sciences, INC. | $24.08 | 2019-2020 | |
| Averitas Pharma INC. | $23.37 | 2023 | Qutenza |
| Kci USA, INC. | $20.92 | 2020 | |
| Kuros Biosciences USA, INC | $19.96 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.98 | 2019 | |
| Integra Lifesciences Corporation | $17.89 | 2020 | |
| Allergan, INC. | $16.16 | 2020 | |
| Becton, Dickinson and Company | $16.11 | 2024 | Venclose Maven Catheter |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.05 | 2023 | Jublia |
| Arthrosurface Incorporated | $14.02 | 2019 | |
| Ethicon US, LLC | $13.86 | 2023 | Stratafix, Vistaseal |
| Abbott Laboratories | $13.55 | 2023 | Proclaim |
| Ermi LLC | $13.38 | 2019 | |
| Medtronic, INC. | $12.80 | 2023 | Intellis Adaptivestim |
| Assertio Therapeutics, INC. | $11.42 | 2020 | |
| Kerecis Limited | $10.80 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.